¹â¸F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma
10.1007/s13139-019-00597-8
- Author:
Riccardo LAUDICELLA
1
;
Guido DAVIDZON
;
Shreyas VASANAWALA
;
Sergio BALDARI
;
Andrei IAGARU
Author Information
1. Department of Biomedical and Dental Sciences and of Morpho-functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy. riclaudi@hotmail.it
- Publication Type:Case Report
- From:Nuclear Medicine and Molecular Imaging
2019;53(4):296-299
- CountryRepublic of Korea
- Language:English
-
Abstract:
We described the clinical impact of ¹â¸F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma.We detailed the diagnostic imaging workup focusing our attention on the CT, MR, and ¹â¸F-FDG PET/MR different findings. In this case, ¹â¸F-FDG PET/MR imaging evaluation resulted not only effective but also altered staging and spared additional invasive procedures in the assessment of a metastatic urethral adenocarcinoma. Combining a highly sensitive PET with the increase tissue resolution of MR (PET/MR) may improve abdominal and pelvic lesion detection outperforming PET/CT for this indication.
